Literature DB >> 7525816

The high-output nitric oxide pathway: role and regulation.

Q Xie1, C Nathan.   

Abstract

Nitric oxide synthase (NOS) catalyzes the production of nitric oxide (NO), a short-lived radical gas with physiological or pathophysiological roles in nearly every organ system. The inducible NO synthase (iNOS) is a high-output isoform compared to the two constitutive NOSs. The iNOS from murine macrophages tightly binds calmodulin as a subunit, and its activity is not dependent on exogenous calmodulin or elevated calcium. This iNOS is induced at the transcriptional level by bacterial lipopolysaccharide (LPS) and interferon-gamma. The promoter region of the murine iNOS gene contains at least 24 oligonucleotide motifs corresponding to elements involved in the binding of transcription factors in the promoters of other cytokine-inducible genes. Nuclear factor NF-kappa B/c-rel, interacting with cycloheximide-sensitive protein(s) and binding to the NF-kappa Bd site in the iNOS promoter, controls the induction of iNOS by LPS. However, iNOS is also regulated posttranscriptionally. Complex regulation of iNOS at multiple levels may reflect the dual role of iNOS in host defense and autotoxicity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525816     DOI: 10.1002/jlb.56.5.576

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  79 in total

Review 1.  Nasal nitric oxide in man.

Authors:  J O Lundberg; E Weitzberg
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Expression of inducible nitric oxide synthase in human gastric cancer.

Authors:  Yu Jun; Guo Fei; Matthias P A Ebert; Peter Malfertheiner
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

Review 3.  Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: a gateway to atherosclerosis.

Authors:  José Delgado Alves; Bruno Grima
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

4.  Differential expression of inducible nitric oxide synthase gene by alveolar and peritoneal macrophages in lipopolysaccharide-hyporesponsive C3H/HeJ mice.

Authors:  M J Wang; K C Jeng; P C Shih
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

5.  Chamomile: an anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity.

Authors:  Natarajan Bhaskaran; Sanjeev Shukla; Janmejai K Srivastava; Sanjay Gupta
Journal:  Int J Mol Med       Date:  2010-12       Impact factor: 4.101

6.  Neuroprotective effects of cactus polysaccharide on oxygen and glucose deprivation induced damage in rat brain slices.

Authors:  Xianju Huang; Qin Li; Yingpei Zhang; Qing Lü; Lianjun Guo; Lin Huang; Zhi He
Journal:  Cell Mol Neurobiol       Date:  2007-08-22       Impact factor: 5.046

7.  Structural and functional characterization of the nitrite channel NirC from Salmonella typhimurium.

Authors:  Wei Lü; Nikola J Schwarzer; Juan Du; Elke Gerbig-Smentek; Susana L A Andrade; Oliver Einsle
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

8.  Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-beta1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice.

Authors:  C W Yang; C C Yu; Y C Ko; C C Huang
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

9.  Nitric oxide and promotion of cardiac myocyte apoptosis.

Authors:  Péter Andréka; Thanh Tran; Keith A Webster; Nanette H Bishopric
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

10.  Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.

Authors:  G J Southan; B Zingarelli; M O'Connor; A L Salzman; C Szabó
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.